Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment



Treatment's subsections
Activator Protein-1 Inhibitor
AdalimuMAb (Approved)
Anti-BLyS MAb.
Bacterial Toxin
CD80 AntAgonists.
Celecoxib (Approved)
CertolizuMAb Pegol (Phase III)
Complement Inhibitors.
Cox-2 Inhibitors (Pain Control)
Device.
DHODH Inhibitors (Vidofludimus)
Etanercept (Approved)
Etoricoxib (Approved>India)
Fostamatinib DiNa (Oral Syk Inh.)
GlucoCorticoid
GolimuMAb (Phase III)
HydroxyChloroQuine.
ImmunoSuppressant Therapy
Indolin-2-One Derivatives
InflixiMAb
InterLeukin (IL) Inhibitors
Leflunomide
Lumiracoxib (Approved)
Masitinib (Tyrosine Kinase Inh.)
MetalloProtease Inhibitor
Methotrexate
Monoclonal T Cell Receptor (mTCR)
Nabumetone
Naproxen(NSAID)
Naproxen(NSAID)+EsomeprAzole (PPI)
Naproxen(NSAID)+LansoprAzole (PPI)
NeuroKinin (Substance P) Inhibitors
OfatumuMAb (Phase III)
OsteoProteGerin (Protein)
p38 MAP Kinase Inhibitor Program
Paclitaxel
Prednisone Modified Release (NSAID)
Protein Therapeutics
RANK Ligand (RANKL).
RituxiMAb (Approved)
TachyKinin Receptor Antagonists
Tumor Necrosis Factor Inhibitors

Treatment's products
This section has no products